Zydus Lifesciences is currently trading at Rs. 375.20, up by 0.05 points or 0.01% from its previous closing of Rs. 375.15 on the BSE.
The scrip opened at Rs. 376.30 and has touched a high and low of Rs. 379.00 and Rs. 375.15 respectively. So far 21216 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 673.70 on 12-May-2021 and a 52 week low of Rs. 331.00 on 07-Mar-2022.
Last one week high and low of the scrip stood at Rs. 379.00 and Rs. 362.95 respectively. The current market cap of the company is Rs. 38661.64 crore.
The promoters holding in the company stood at 74.88%, while Institutions and Non-Institutions held 15.66% and 9.46% respectively.
Zydus Lifesciences has entered into Share Purchase, Subscription and Shareholder’s Agreement (SPSSA) to acquire up to 11.86% stake on a fully diluted basis in AMP Energy Green Nine, for setting up captive Wind Solar Hybrid power project in Gujarat. This is in line with the company’s the commitment to enhance the share of renewable power source in its operation and to comply with regulatory requirement for being a ‘captive user’ under Electricity Laws, 2003.
Zydus Lifesciences is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1858.70 |
Dr. Reddys Lab | 1258.55 |
Cipla | 1559.20 |
Lupin | 2198.25 |
Zydus Lifesciences | 1004.00 |
View more.. |